Plain language summary of SUNLIGHT: trifluridine/tipiracil and bevacizumab for refractory metastatic colorectal cancer

Thumbnail
View
Author
Prager, M.D., Gerald ORCID
taieb, julien ORCID
Fakih, Marwan ORCID
Ciardiello, Fortunato ORCID
Van Cutsem, Eric ORCID
Elez, Elena ORCID
Date
2024
Permanent link
https://hdl.handle.net/11351/12255
DOI
10.1080/14796694.2024.2366100
ISSN
1744-8301
WOS
001261075800001
PMID
38953855
Share on TwitterShare on FacebookShare on TelegramShare on WhatsappShare on Linkedin

Show full item record
Keywords
Colorectal; Metastasis; Refractory
Bibliographic citation
Prager GW, Taieb J, Fakih M, Ciardiello F, Van Cutsem E, Élez E, et al. Plain language summary of SUNLIGHT: trifluridine/tipiracil and bevacizumab for refractory metastatic colorectal cancer. Futur Oncol. 2024;20(36):2823–32.
Audience
Professionals
This item appears in following collections

The following license files are associated with this item: